Eliquis 5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FA1L8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,555
Award facts
- Contract value 100% obligated
- $41,554.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $41,554.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, with a completion date of January 7, 2026. This non-set-aside award, issued on January 6, 2026, is a child order executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. That primary IDC, valued at $999,999,999.00 through December 2026, serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains.
The pharmaceutical product delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis, an anticoagulant medication used to reduce the risk of blood clots and stroke in patients with atrial fibrillation and other conditions, is a critical pharmaceutical commodity within the Defense Health Agency's medical supply chain. This delivery order exemplifies AmerisourceBergen's ongoing role as a primary pharmaceutical distributor for federal military healthcare systems, competing on a full and open basis to fulfill essential medical supply requirements across the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26FA1L8?
SPE2DR26FA1L8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FA1L8 worth?
The government has obligated $41,555 on SPE2DR26FA1L8.
Is contract SPE2DR26FA1L8 an order under another contract?
Yes. SPE2DR26FA1L8 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA1L8 competed?
The extent of competition for SPE2DR26FA1L8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award